|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/40 | |
| C12Q 1/68 | |||
| C12Q 1/6876 | |||
| C12Q 1/6886 | |||
| C12N 9/00 | |||
| A61K 38/00 | |||
| G01N 33/573 |
| (11) | Number of the document | 3255146 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17169885.5 |
| Date of filing the European patent application | 2010-03-16 | |
| (97) | Date of publication of the European application | 2017-12-13 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 160630 P | 2009-03-16 | US | |
| 239747 P | 2009-09-03 | US |
| (72) |
Zhou, Jie, HK
Lau, Ching Fun, HK
Xu, Zhiwen, HK
Lo, Wing Sze, HK
Piehl, Kristi Helen, US
Greene, Leslie Ann, US
|
| (73) |
Pangu Biopharma Limited,
Edinburgh Tower, 18/F The Landmark 15 Queen`s Road Central, Hong Kong,
CN
aTyr Pharma, Inc., 3565 General Atomics Court, Suite 103, San Diego CA 92121, US |
| (54) | COMPOSITIONS AND METHODS COMPRISING HISTIDYL-TRNA SYNTHETASE SPLICE VARIANTS HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |
| COMPOSITIONS AND METHODS COMPRISING HISTIDYL-TRNA SYNTHETASE SPLICE VARIANTS HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |